Literature DB >> 20708078

Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.

Wing S To1, Kim S Midwood.   

Abstract

The three-dimensional organization of the ubiquitous extracellular matrix glycoprotein fibronectin regulates cell fate and morphogenesis during development; in particular tubule formation that constitutes the vasculature, lung and kidney. Tenascin-C is a matrix protein with a restricted expression pattern; it is specifically up-regulated at sites of fibronectin fibril assembly during development and in remodeling adult tissues. Here we demonstrate that specific domains of tenascin-C inhibit fibronectin matrix assembly whereas full-length tenascin-C does not. These domains act via distinct mechanisms: TNfn1-8 blocks fibrillogenesis by binding to fibronectin fibrils and preventing intermolecular fibronectin interactions whilst FBG acts independently of binding to fibronectin and instead is internalized and causes cytoskeletal re-organization. We also show that TNfn1-8 disrupts epithelial cell tubulogenesis. Our data demonstrate that tenascin-C contains cryptic sites which can control tissue levels of fibrillar fibronectin either by preventing de novo fibril assembly or reducing levels of deposited fibronectin. Exposure of these domains during tissue remodeling may provide a novel means of controlling fibronectin assembly and tubulogenic processes dependent on the assembly of this matrix.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708078     DOI: 10.1016/j.matbio.2010.08.003

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  10 in total

1.  Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin.

Authors:  Wing S To; Kim S Midwood
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

2.  The effects of tenascin C knockdown on trabecular meshwork outflow resistance.

Authors:  Kate E Keller; Janice A Vranka; Ramez I Haddadin; Min-Hyung Kang; Dong-Jin Oh; Douglas J Rhee; Yong-Feng Yang; Ying Ying Sun; Mary J Kelley; Ted S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-19       Impact factor: 4.799

Review 3.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

4.  Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.

Authors:  Sabrina Ruggiero; Raluca Cosgarea; Jan Potempa; Barbara Potempa; Sigrun Eick; Matthias Chiquet
Journal:  Biochim Biophys Acta       Date:  2013-01-09

5.  Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors.

Authors:  Chunbo Zou; Rujuan Xie; Yushi Bao; Xiaogang Liu; Manshu Sui; Suhong M; Shuang Li; Huiqing Yin
Journal:  Endocrine       Date:  2013-03-07       Impact factor: 3.633

6.  Different forms of tenascin-C with tenascin-R regulate neural differentiation in bone marrow-derived human mesenchymal stem cells.

Authors:  Hung-Li Tsai; Wen-Ta Chiu; Chia-Lang Fang; Shiaw-Min Hwang; Perry F Renshaw; Wen-Fu Thomas Lai
Journal:  Tissue Eng Part A       Date:  2014-07       Impact factor: 3.845

7.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16

Review 8.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

9.  The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.

Authors:  Yingqiang Xu; Zhonghu Li; Peng Jiang; Guo Wu; Kai Chen; Xi Zhang; Xiaowu Li
Journal:  Diagn Pathol       Date:  2015-12-10       Impact factor: 2.644

Review 10.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.